October 5, 2007
Nursing Homes Owned by Private Equity Firms Worse in Quality?
Analysis: Skilled nursing facilities (SNFs) are a growth industry -as the population ages, more and more beds are needed. The model of the SNF is quite different from the hospital. There are certainly short term residents being treated for wounds, receiving IV medications, being given physical rehabilitation etc. But for the most part resident conditions are chronic and long term. Patrients are basically stable and are in the institution for extended periods. Visits by doctors are less frequent and nurse patient ratios are much lower (1 nurse has more patients than in a hospital). Much of the routine care is delivered by less skilled, lower paid assistive personnel.
Medicare reimbursement to SNFs has decreased in recent years so operators often claim "where hospitals look at margins in dollars, we look at cents!". Successful operators have certainly learned some tricks of the trade to stay viable, but they are always looking for opportunities such as that offered by equity firms. Recently equity firms have made some profitable takeovers; sometimes in all-cash transactions. The shareholders of publicly traded SNFs often receive premiums of 15-20% on their stocks in a takeover.
The equity firms on the other hand see a growth industry with great census, the possibility to realize healthy margins by putting into place operational efficiencies. Sounds like a good investment. Sounds like a real win/win situation.
How lean are these operational "efficiencies" though? There have been a rash of complaints directed at nursing homes acquired by private equity firms that have been accused of reducing staff to a dangerous level, removing basic safety/quality measures to save money and so on. This article about Habana health Care in Tampa, FL is a classic example
SNFs have long been the target of claims of abuse and neglect. If homes acquired by equity firms are guilty of a pattern of substandard care and safety violations simply to enhance profits, then we need to get to the bottom of that and react accordingly. It is not necessary to adopt unsafe shortcuts to generate profits. I work with companies every day that adopt operational efficiencies while maintaining regulatory standards and delivering exemplary quality of care.
It will be of interest to everyone in the long term care industry to see how this probe turns out. I hope any change is reasonable and reasoned and not overly restrictive or so broad free enterprise is stifled. Changes can be good for business and good for patients at the same time.
Report a Concern
More GLG News in
Healthcare
ADAGIO Trial Results Show Teva's AZILECT(R) 1 Mg Tablets Slow Progression Of Parkinson's Disease
www.medicalnewstoday.com
Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
www.therapeuticsdaily.com
Expanding Circle of Inhibition: Small-Molecule Inhibitors of Bcl-2 as Anticancer Cell and Antiangiogenic Agents
jco.ascopubs.org
ACE Inhibitor May Ease Cardiac Risks in Marfan's Syndrome
www.medpagetoday.com
Healthways' Guidance Not So Healthy
www.forbes.com
Azilect
September 2, 2008
Byetta Saves Lives
September 2, 2008
The Devil Is in the Details
September 1, 2008
Dangers of Methadone Usage
August 28, 2008
Healthways A Market Downturn and Results
August 26, 2008

